InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+1.9%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Kramer Kelly A., Director. Director active across 5 companies, notably Gilead Sciences, INC.. Cumulatively, 15 disclosures have been recorded. Activity tracked since 8 July 2021. The latest transaction was filed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
1,268 sharesClass A Common StockSEC:0001679788-26-000070:0
12,415 shares0Class A Common StockSEC:0001629885-26-000004:0
2,806 shares@ US$81.000.0001% mcap50.0% of flowCommon StockSEC:0001629885-25-000005:0
1,373 shares0Common StockSEC:0001640147-25-000154:0
1,533 shares0Class A Common StockSEC:0001679788-25-000122:0
2,292 shares0Class A Common StockSEC:0001640147-24-000191:0
6,294 shares0Class A Common StockSEC:0001679788-24-000117:0
1,695 shares0Class A Common StockSEC:0001640147-23-000154:0
5,199 shares0Class A Common StockSEC:0001679788-23-000086:0
9,670 shares0Class A Common StockSEC:0001679788-23-000034:0
2,217 shares0Class A Common StockSEC:0001640147-22-000070:0
1,270 shares0Class A Common StockSEC:0001679788-22-000059:0
9,671 shares0Class A Common StockSEC:0001679788-22-000017:0
1,224 shares0Class A Common StockSEC:0001640147-21-000166:0
29,370 sharesCommon StockSEC:0001140361-16-052427:0
15 of 15 declarations
About Kramer Kelly A.
Kelly A. Kramer is a Director of GILEAD SCIENCES, INC., Snowflake Inc., and Coinbase Global, Inc. She plays a key role in the strategic direction of these companies, ensuring that decisions made align with growth and innovation objectives.
